{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:00:54Z","timestamp":1791216054469,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["neurotox res"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/bf03033367","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:31:04Z","timestamp":1248111064000},"page":"49-61","source":"Crossref","is-referenced-by-count":26,"title":["Huperzine a provides neuroprotection against several cell death inducers usingin vitro model systems of motor neuron cell death"],"prefix":"10.1007","volume":"13","author":[{"given":"Richelle A.","family":"Hemendinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal","family":"Persinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Mougeot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Volvovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03033367_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","volume":"52","author":"S Boillee","year":"2006","unstructured":"Boillee S, VC Vande and DW Cleveland (2006) ALS: a disease of motor neurons and their nonneuronal neighbors.Neuron 52, 39\u201359.","journal-title":"Neuron"},{"key":"BF03033367_CR2","first-page":"551","volume-title":"Amyotrophic Lateral Sclerosis","author":"T Bordet","year":"2006","unstructured":"Bordet T, R Pruss and CE Henderson (2006) Screening for ALS drugs, In:Amyotrophic Lateral Sclerosis (Mitsumoto S, S Przedborski and PH Gordon, Eds.) (Taylor & Francis Group:New York, NY, USA), pp 551\u2013582."},{"key":"BF03033367_CR3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","volume":"302","author":"AM Clement","year":"2003","unstructured":"Clement AM, MD Nguyen, EA Roberts, ML Garcia, S Boillee, M Rule, AP Mahon, W Doucette, D Siwek, RJ Ferrante, RH Brown Jr, JP Julien, LS Goldstein and DW Cleveland (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.Science 302, 113\u2013117.","journal-title":"Science"},{"key":"BF03033367_CR4","first-page":"386","volume":"54","author":"S Cluskey","year":"2001","unstructured":"Cluskey S and DB Ramsden (2001) Mechanisms of neurodegeneration in amyotrophic lateral sclerosis.Mol. Pathol. 54, 386\u2013392.","journal-title":"Mol. Pathol."},{"key":"BF03033367_CR5","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1021\/bi020151+","volume":"41","author":"H Dvir","year":"2002","unstructured":"Dvir H, HL Jiang, DM Wong, M Harel, M Chetrit, XC He, GY Jin, GL Yu, XC Tang, I Silman, DL Bai and JL Sussman (2002) X-ray structures ofTorpedo californica acetylcholinesterase complexed with (+)-huperzine A and (-)-huperzine B: structural evidence for an active site rearrangement.Biochemistry 41, 10810\u201310818.","journal-title":"Biochemistry"},{"key":"BF03033367_CR6","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/jnr.20791","volume":"83","author":"X Gao","year":"2006","unstructured":"Gao X anc XC Tang (2006) Huperzine A attenuates mitochondrial dysfunction in beta-amyloid-treated PC 12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism.J. Neurosci. Res. 83, 1048\u20131057.","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"BF03033367_CR7","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/jat.805","volume":"21","author":"RK Gordon","year":"2001","unstructured":"Gordon RK, S V Nigam, JA Weitz, JR Dave, BP Doctor and HS Ved (2001) The NMDA receptor ion channel: a site for bind- ing of Huperzine A.J. Appl. Toxicol. 21 Suppl. 1, S47-S51.","journal-title":"J. Appl. Toxicol."},{"key":"BF03033367_CR8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI200317610","volume":"111","author":"C Guegan","year":"2003","unstructured":"Guegan C and S Przedborski (2003) Programmed cell death in amyotrophic lateral sclerosis.J. Clin. Invest. 111, 153\u2013161.","journal-title":"J. Clin. Invest."},{"key":"BF03033367_CR9","first-page":"229","volume":"11","author":"RA Hemendinger","year":"1998","unstructured":"Hemendinger RA and SE Bloom (1998) Differential induction of apoptosis and cell cycle inhibition by the mitochondrial poisons Rhodamine 123 and carbonyl cyanide m-chlorophenyl in B lymphomavs T lyphoma cells.In Vitro Mol. Toxicol. 11, 229\u2013242.","journal-title":"In Vitro Mol. Toxicol."},{"key":"BF03033367_CR10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2005.07.025","volume":"196","author":"R Hemendinger","year":"2005","unstructured":"Hemendinger R, J Wang, S Malik, R Persinski, J Copeland, D Emerich, P Gores, C Halberstadt and J Rosenfeld (2005) Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis.Exp. Neurol. 196, 235\u2013243.","journal-title":"Exp. Neurol."},{"key":"BF03033367_CR11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00005072-199810000-00002","volume":"57","author":"PG Ince","year":"1998","unstructured":"Ince PG, J Tomkins, JY Slade, NM Thatcher and PJ Shaw (1998) Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu\/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS.J. Neuropathol. Exp. Neurol. 57, 895\u2013904.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03033367_CR12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3233\/JAD-2004-6601","volume":"6","author":"EG Jorda","year":"2004","unstructured":"Jorda EG, E Verdaguer, A Jim\u00e9nez, AM Canudas, V Rimbau P Camps, D Mu\u00f1oz-Torrero, A Camins and M Pall\u00e0s (2004) (\u00b1)-huprine Y, (-)-huperzine A and tacrine do not show neu- roprotective properties in an apoptotic model of neuronal cytoskeletal alteration.J. Alzheimer\u2019s Dis. 6, 577\u2013583.","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"BF03033367_CR13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.bcp.2005.04.036","volume":"70","author":"EG Jorda","year":"2005","unstructured":"Jorda EG, E Verdaguer, A Jim\u00e9nez, SG de Arriba, C Allgaier, M Pall\u00e0s and A Camins (2005) Evaluation of the neuronal apoptotic pathways involved in cytoskeletal disruptioninduced apoptosis.Biochem. Pharmacol. 70, 470\u2013480.","journal-title":"Biochem. Pharmacol."},{"key":"BF03033367_CR14","first-page":"665","volume-title":"Amyotrophic Lateral Sclerosis","author":"P Kaufmann","year":"2006","unstructured":"Kaufmann P (2006) ALS pharmacolotherapy: riluzole and clinical trials, In:Amyotrophic Lateral Sclerosis (Mitsumoto S, S Przedborski and PH Gordon, Eds.) (Taylor & Francis Group:New York, NY, USA), pp 665\u2013689."},{"key":"BF03033367_CR15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/hum.2005.16.509","volume":"16","author":"SM Klein","year":"2005","unstructured":"Klein SM, S Behrstock, J McHugh, K Hoffmann, K Wallace, M Suzuki, P Aebischer and CN Svendsen (2005) GDNF delivery using human neural progenitor cells in a rat model of ALS.Hum. Gene Ther. 16, 509\u2013521.","journal-title":"Hum. Gene Ther."},{"key":"BF03033367_CR16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","volume":"347","author":"L Lacomblez","year":"1996","unstructured":"Lacomblez L, G Bensimon, PN Leigh, P Guillet and V Meininger (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II.Lancet 347, 1425\u20131431.","journal-title":"Lancet"},{"key":"BF03033367_CR17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/35012636","volume":"405","author":"MS Lee","year":"2000","unstructured":"Lee MS, YT Kwan, M Li, J Peng, RM Friedlander and LH Tsai (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain.Nature 405, 360\u2013364.","journal-title":"Nature"},{"key":"BF03033367_CR18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1749-6632.1998.tb09954.x","volume":"854","author":"YX Ma","year":"1998","unstructured":"Ma YX, Y Zhu, Q Gu and L He (1998) Double-blind trial of huperzine-A (HUP) on cognitive deterioration in 314 cases of benign senescent forgetfulness, vascular dementia and Alzheimer\u2019s disease.Ann. NYAcad. Sci. 854, 506\u2013507.","journal-title":"Ann. NYAcad. Sci."},{"key":"BF03033367_CR19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0014-2999(93)90037-I","volume":"250","author":"D Martin","year":"1993","unstructured":"Martin D, MA Thompson and JV Nadler (1993) The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1.Eur. J. Pharmacol. 250, 473\u2013476.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033367_CR20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(91)90730-E","volume":"203","author":"M McKinney","year":"1991","unstructured":"McKinney M, JH Miller, F Yamada, W Tuckmantel and AP Kozikowski (1991) Potencies and stereoselectivities of enantiomers of huperzine A for inhibition of rat cortical acetylcholinesterase.Eur. J. Pharmacol. 203, 303\u2013305.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033367_CR21","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1523\/JNEUROSCI.23-06-02131.2003","volume":"23","author":"MD Nguyen","year":"2003","unstructured":"Nguyen MD, M Boudreau, J Kriz, S Couillard-Despr\u00e9s, DR Kaplan and J-P Julien (2003) Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1.J. Neurosci. 23, 2131\u20132140.","journal-title":"J. Neurosci."},{"key":"BF03033367_CR22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0091-679X(08)60508-7","volume-title":"Methods in Cell Biology: Flow Cytometry","author":"A Pollak","year":"1990","unstructured":"Pollak A and G Ciancio (1990) Cell cycle phase-specific analysis of cell viability using Hoechst 33342 and propidium iodide after ethanol preservation, In:Methods in Cell Biology: Flow Cytometry (Darzynkiewicz Z and H Crissman, Eds.) (Academic Press:San Diego, CA, USA), pp 19\u201324."},{"key":"BF03033367_CR23","doi-asserted-by":"crossref","first-page":"54518","DOI":"10.1074\/jbc.M408186200","volume":"279","author":"A Rametti","year":"2004","unstructured":"Rametti A, F Esclaire, C Yardin and F Terro (2004) Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis.J. Biol. Chem. 279, 54518\u201354528.","journal-title":"J. Biol. Chem."},{"key":"BF03033367_CR24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9440(10)63879-5","volume":"162","author":"S Ranganathan","year":"2003","unstructured":"Ranganathan S and R Bowser (2003) Alterations in G1 to S phase cell-cycle regulators during amyotrophic lateral sclerosis.Am. J. Pathol. 162, 823\u2013835.","journal-title":"Am. J. Pathol."},{"key":"BF03033367_CR25","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1073\/pnas.90.14.6591","volume":"90","author":"JD Rothstein","year":"1993","unstructured":"Rothstein JD, L Jin, M Dykes-Hoberg and RW Kuncl (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.Proc. Natl. Acad. Sci. USA 90, 6591\u20136595.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03033367_CR26","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/jnnp.2004.048652","volume":"76","author":"PJ Shaw","year":"2005","unstructured":"Shaw PJ (2005) Molecular and cellular pathways of neurodegeneration in motor neurone disease.J. Neurol. Neurosurg. Psychiatry 76, 1046\u20131057.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BF03033367_CR27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jnr.20051","volume":"76","author":"SB Shelton","year":"2004","unstructured":"Shelton SB, P Krishnamurthy and GVW Johnson (2004) Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain corti- cal cells.J. Neurosci. Res. 76, 110\u2013120.","journal-title":"J. Neurosci. Res."},{"key":"BF03033367_CR28","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00002281-200311000-00008","volume":"15","author":"EP Simpson","year":"2003","unstructured":"Simpson EP, AA Yen and SH Appel (2003) Oxidative stress, a common denominator in the pathogenesis of amyotrophic lateral sclerosis.Curr. Opin. Rheumatol. 15, 730\u2013736.","journal-title":"Curr. Opin. Rheumatol."},{"key":"BF03033367_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2005.06.026","volume":"519","author":"LL Tang","year":"2005","unstructured":"Tang LL, R Wang and XC Tang (2005) Huperzine A protects SHSY5Y neuroblastoma cells against oxidative stress damage via nerve growth factor production.Eur. J. Pharmacol. 519, 9\u201315.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033367_CR30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/jnr.490240220","volume":"24","author":"XC Tang","year":"1989","unstructured":"Tang XC, SP De, K Sugaya and E Giacobini (1989) Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat.J. Neurosci. Res. 24, 276\u2013285.","journal-title":"J. Neurosci. Res."},{"key":"BF03033367_CR31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1742-7843.2007.00041.x","volume":"100","author":"C Wang","year":"2007","unstructured":"Wang C, XC Zhang, H Ma, J Liu, F Fu and K Liu (2007) Prolonged effects of poly(lactic-cp-glycolic acid) microspherecontaining huperzine A on mouse memory dysfunction induced by scopolamine.Basic Clin. Pharmacol. Toxicol. 100, 190\u2013195.","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"BF03033367_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000085387","volume":"14","author":"R Wang","year":"2005","unstructured":"Wang R and XC Tang (2005) Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer\u2019s disease.Neurosignals 14, 71\u201382.","journal-title":"Neurosignals"},{"key":"BF03033367_CR33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-2999(01)01030-5","volume":"421","author":"R Wang","year":"2001","unstructured":"Wang R, HY Zhang and XC Tang (2001) Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat.Eur. J. Pharmacol. 421, 149\u2013156.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033367_CR34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jnr.10075","volume":"67","author":"XQ Xiao","year":"2002","unstructured":"Xiao XQ, HY Zhang and XC Tang (2002) Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation.J. Neurosci. Res. 67, 30\u201336.","journal-title":"J. Neurosci. Res."},{"key":"BF03033367_CR35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(03)00023-5","volume":"340","author":"HY Zhang","year":"2003","unstructured":"Zhang HY and XC Tang (2003) Huperzine A attenuates the neurotoxic effect of staurosporine in primary rat cortical neurons.Neurosci. Lett. 340, 91\u201394.","journal-title":"Neurosci. Lett."},{"key":"BF03033367_CR36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(01)02437-5","volume":"317","author":"HY Zhang","year":"2002","unstructured":"Zhang HY, YQ Liang, XC Tang, XC He and DL Bai (2002) Stereoselectivities of enantiomers of huperzine A in protection against beta-amyloid (25-35)-induced injury in PC 12 and NG108-15 cells and cholinesterase inhibition in mice.Neurosci. Lett. 317, 143\u2013146.","journal-title":"Neurosci. Lett."},{"key":"BF03033367_CR37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1745-7254.2007.00486.x","volume":"28","author":"YJ Zhao","year":"2007","unstructured":"Zhao YJ, P Yue, T Tao and QH Chen (2007) Drug brain distribution flowing intranasal administration of Huperzine Ain situ gel in rats.Acta Pharmacol. Sin. 28, 273\u2013278.","journal-title":"Acta Pharmacol. Sin."},{"key":"BF03033367_CR38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-5793(02)03107-1","volume":"526","author":"J Zhou","year":"2002","unstructured":"Zhou J and XC Tang (2002) Huperzine A attenuates apoptosis and mitochondria-dependent caspase-3 in rat cortical neurons.FEBSLett. 526, 21\u201325.","journal-title":"FEBSLett."},{"key":"BF03033367_CR39","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1097\/00001756-200107200-00007","volume":"12","author":"J Zhou","year":"2001","unstructured":"Zhou J, Y Fu and XC Tang (2001) Huperzine A protects ratpheochromocytoma cells against oxygen-glucose deprivation.Neuroreport 12, 2073\u20132077.","journal-title":"Neuroreport"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03033367\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T23:32:18Z","timestamp":1558481538000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03033367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["BF03033367"],"URL":"https:\/\/doi.org\/10.1007\/bf03033367","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}